First Hawaiian Bank’s Amedisys AMED Stock Holding History

First Hawaiian Bank’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-415	Closed	-$49K	–	1709
2018 Q4	$49K	Buy	415 +130	+46%	+$15.3K	﹤0.01%	1066
2018 Q3	$36K	Buy	+285	New	+$31.5K	﹤0.01%	1239

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

First Hawaiian Bank's AMED Position: Q1 2019 in Review

First Hawaiian Bank sold out of Amedisys (AMED) in Q1 2019, closing a stake of 415 shares — an estimated $49K sold.

First Hawaiian Bank first reported a position in AMED in Q3 2018 and held it in 2 quarters. The position peaked at $49K in Q4 2018. 317 funds tracked by Wall St. Rank hold AMED as of Q1 2019.

First Hawaiian Bank reported no remaining Amedisys position as of Q1 2019 after selling out during the quarter.
First Hawaiian Bank sold 415 Amedisys shares in Q1 2019, an estimated $49K.
First Hawaiian Bank first reported a position in Amedisys in Q3 2018 and held it in 2 quarters.
First Hawaiian Bank's Amedisys position peaked at $49K in Q4 2018.
317 funds tracked by Wall St. Rank held Amedisys as of Q1 2019.

Based on First Hawaiian Bank's 13F filing for Q1 2019, filed 2 Apr 2019.